Assessment of therapeutic benefit of antiviral therapy in chronic hepatitis C: is hepatic venous pressure gradient a better end point?

Chronic hepatitis C is a major healthcare problem. The response to antiviral therapy for patients with chronic hepatitis C has previously been defined biochemically and by PCR. However, changes in the hepatic venous pressure gradient (HVPG) may be considered as an adjunctive end point for the therap...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Burroughs, A K, Groszmann, R, Bosch, J, Grace, N, Garcia-Tsao, G, Patch, D, Garcia-Pagan, J C, Dagher, L
Médium: Artigo
Jazyk:Inglês
Vydáno: Copyright 2002 by Gut 2002
Témata:
Occasional Viewpoint
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC1773121/
https://ncbi.nlm.nih.gov/pubmed/11839726
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky